Janus Kinase Inhibitors and Risk of Venous Thromboembolism: A Systematic Review and Meta-analysis

To assess the risk of venous thromboembolism (VTE) in patients treated with Janus kinase (JAK) inhibitors in clinical trials.

Source: Mayo Clinic Proceedings - April 8, 2021 Category: Internal Medicine Authors: Jawad Bilal, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, Sandipan Bhattacharjee, Michelle R. Obert, Maryam Sadiq, Mohammad A. Abd El Aziz, Yahya Nooman, Lary J. Prokop, Long Ge, Mohammad H. Murad, Alan H. Bryce, Robert D. McBane, C. Kent Kwoh Tags: Original article Source Type: research